Events

Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccineContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"

Alexander Birkmann, PhD, is a seasoned pharmaceutical professional with over 20 years of experience in antiviral drug development. He has held key positions at Bayer and AiCuris, contributing to theContinue reading "AiCuris: Dr. Alex Birkmann on Antiviral Drug Development for HSV"